尽管使用糖尿病技术,1型糖尿病患者中严重低血糖和低血糖感知受损仍持续存在:一项横断面调查结果
该回顾性观察研究纳入2074例1型糖尿病成人患者,通过一次性在线调查评估血糖指标、严重低血糖事件和低血糖感知受损。尽管91.7%使用持续葡萄糖监测、50.8%使用自动胰岛素输注系统,仅57.7%报告达到血糖目标(HbA1c<7%),约20%在过去12个月内经历至少一次严重低血糖事件,30.7%(95%CI 28.7,32.7)报告低血糖感知受损,与是否使用持续葡萄糖监测或自动胰岛素输注系统无关。
要点
- 91.7%使用持续葡萄糖监测、50.8%使用自动胰岛素输注,仅57.7%达到HbA1c<7%目标。
- 约20%受访者在过去12个月内经历至少一次严重低血糖事件。
- 30.7%(95%CI 28.7,32.7)报告低血糖感知受损,与持续葡萄糖监测或自动胰岛素输注使用无关。
核心结论
- 尽管使用先进糖尿病技术,高比例1型糖尿病患者未达到血糖目标,并继续经历严重低血糖事件和低血糖感知受损,提示持续需要改进治疗策略。
研究设计与样本
- 回顾性、观察性研究,包含横断面元素;参与者年龄≥18岁,来自T1D Exchange登记处/在线社区,完成一次性在线调查,描述血糖指标、严重低血糖事件和低血糖感知受损,共纳入2074例1型糖尿病患者。
主要发现
- 平均±标准差年龄43.0±15.6岁,1型糖尿病病程26.3±15.3年。
- 91.7%使用持续葡萄糖监测,50.8%使用自动胰岛素输注系统。
- 仅57.7%报告达到血糖目标(血红蛋白A1c<7%)。
- 约20%受访者在过去12个月内经历至少一次严重低血糖事件。
- 30.7%(95%CI 28.7,32.7)报告低血糖感知受损,与持续葡萄糖监测或自动胰岛素输注使用无关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine how diabetes technologies, including continuous glucose monitoring (CGM) and automated insulin delivery (AID) systems, impact glycemic metrics, prevalence of severe hypoglycemic events (SHEs), and impaired awareness of hypoglycemia (IAH) in people with type 1 diabetes in a real-world setting within the U.S. RESEARCH DESIGN AND METHODS: In this retrospective, observational study with cross-sectional elements, participants aged ≥18 years were enrolled from the T1D Exchange Registry/online community. Participants completed a one-time online survey describing glycemic metrics, SHEs, and IAH. The primary objective was to determine the proportions of participants who reported achieving glycemic targets (assessed according to self-reported hemoglobin A1c) and had SHEs and/or IAH. We performed additional subgroup analyses focusing on the impact of CGM and insulin delivery modality. RESULTS: A total of 2,074 individuals with type 1 diabetes were enrolled (mean ± SD age 43.0 ± 15.6 years and duration of type 1 diabetes 26.3 ± 15.3 years). The majority of participants (91.7%) were using CGM, with one-half (50.8%) incorporating AID. Despite high use of diabetes technologies, only 57.7% reported achieving glycemic targets (hemoglobin A1c <7%). SHEs and IAH still occurred, with ∼20% of respondents experiencing at least one SHE within the prior 12 months and 30.7% (95% CI 28.7, 32.7) reporting IAH, regardless of CGM or AID use. CONCLUSIONS: Despite use of advanced diabetes technologies, a high proportion of people with type 1 diabetes do not achieve glycemic targets and continue to experience SHEs and IAH, suggesting an ongoing need for improved treatment strategies.
引用
- Sherr JL, Laffel LM, Liu J, et al. Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Persist in People With Type 1 Diabetes Despite Use of Diabetes Technology: Results From a Cross-sectional Survey. Diabetes Care. 2024. PMID: 38295397. doi:10.2337/dc23-1765
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。